APYX - Apyx Medical - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

APYX is currently covered by 1 analysts with an average price target of $4.96. This is a potential upside of $2.93 (144.33%) from yesterday's end of day stock price of $2.03.

Apyx Medical's activity chart (see below) currently has 33 price targets and 30 ratings on display. The stock rating distribution of APYX is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.54% with an average time for these price targets to be met of 155.25 days.

Highest price target for APYX is $1, Lowest price target is $1.

Most recent stock forecast was given by DAVID TURKALY from JMP on 16-Sep-2024. First documented stock forecast 21-Nov-2016.

Best performing analysts who are covering APYX - Apyx Medical:

David Turkaly Matt O'brien Frank Takkinen Kyle Bauser

Currently out of the existing stock ratings of APYX, 1 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

11 months 4 days ago
(16-Sep-2024)

3/3 (100%)

$1.8 (21.95%)

243

Buy

$4.5

$2.34 (108.33%)

$3

2 years 9 days ago
(11-Aug-2023)

14/16 (87.5%)

$-0.55 (-10.89%)

297

Buy

$9

$6.84 (316.67%)

$6

2 years 2 months 5 days ago
(15-Jun-2023)

2/3 (66.67%)

$2.05 (29.50%)

81

Buy

$17

$15.59 (1105.67%)

$12

3 years 1 months 1 days ago
(19-Jul-2022)

0/2 (0%)

$8.43 (98.37%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is APYX (Apyx Medical) average time for price targets to be met?

On average it took 155.25 days on average for the stock forecasts to be realized with a an average price target met ratio 63.54

Which analyst has the current highest performing score on APYX (Apyx Medical) with a proven track record?

DAVID TURKALY

Which analyst has the current lower performing score on APYX (Apyx Medical) with a proven track record?

KYLE BAUSER

Which analyst has the most public recommendations on APYX (Apyx Medical)?

David Turkaly works at JMP and has 22 price targets and 14 ratings on APYX

Which analyst is the currently most bullish on APYX (Apyx Medical)?

Kyle Bauser with highest potential upside - $15.59

Which analyst is the currently most reserved on APYX (Apyx Medical)?

David Turkaly with lowest potential downside - -$0

Apyx Medical in the News

Apyx Medical outlines $50M–$52M 2025 revenue targets as AYON presales surpass expectations and China launch advances

Earnings Call Insights: Apyx Medical Corporation (APYX) Q2 2025 MANAGEMENT VIEW * Charles D. Goodwin, President and CEO, announced the appointment of two senior sales leaders: “John Featherstone will head North American sales and has over 20 years experience in the aesthetics industry, along with Simon Davies, who will head Europe and Asia and has...

APYX Medical Corp (NASDAQ:APYX) Reports Mixed Q2 2025 Earnings with Revenue Miss and Narrower Loss

APYX MEDICAL CORP (NASDAQ:APYX [https://www.chartmill.com/stock/quote/APYX/profile]) reported its second-quarter 2025 financial results, revealing mixed performance relative to analyst expectations. The company, known for its helium plasma and radiofrequency technology used in cosmetic and surgical markets, posted revenue of $11.37 million, falling short of the consensus estimate of $11.93 million. Earnings per share (EPS) came in at...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?